incretin mimetic agents glp 1 receptor agonists Effects of incretin-based therapies on bone metabolism. GLP-1 glp-1_analogs [TUSOM | Pharmwiki]

It is also important to note GLP-1 drugs can have serious side effects and as many as one in five people naturally won't respond to the drugs and wont lose weight in the process

doi: 10.1159/000521264 Summary Keywords GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism Citation Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, Zhang H-C and Zhang X-F (2023) GLP1 receptor agonists for the treatment of obesity: Role as a promising approach

doi: 10.1016/j.peptides.2017.11.023

As mentioned before, GLP-1R stimulation is able to reduce 6-OHDA-induced cell death in SH-SY5Y cells 62 as well as primary ventral mesencephalic (DAergic) neurons

Clin Pharmacol 13:5360

& Lohmander, L